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THIS paper is a preliminary report on 1626 cases of carcinoma of the breast,
examinedwith a view to assessing the influence ofvarious factorsontheappearance
of the first recurrence.
These patients were seen at the Royal Cancer Hospital in the ten year period
1937-1947, and represent the total number of new patients seen (Smithers,
Rigby-Jones, Galton and Payne, 1952; Table II).
Of these patients 1569 were treated and all have been followed up for at least
5 years, that is, until the end of 1952. Table I shows the full analysis of these
TABLE I.-All New Patients with Cancer of the Breast seen at
the Royal Cancer Hospital, 1937-1947.
Total number of new patients . 1626
Number not treated . . 57
Untraced in December, 1952 . . . . . . 158
Died of intercurrent disease without recurrence . . 101
Alive and free from recurrence . . . . . . 283
Primary tumour not controlled . . . . . . 348
Died of cancer. Site of first recurrence unknown . . 235
Recurrent cases available for purposes of present enquiry . 444
Total number treated . . . . . . 1569
cases at that time. There were 158 still untraced, with no record of their death
at Somerset House, and 101 had died of intercurrent disease without recurrence.
There were 283 alive having shown no sign of recurrence over the whole period in
review. Of the remaining 1027 patients, 348 were advanced cases in which the
primary disease had neverbeen controlled. The remaining 679 patients were those
in whom recurrence had occurred following treatment which had removed all
clinical evidence of the disease. Only 444 of these are suitable for analysis, since
in 235 of them the fact that they died of cancer is only known from the death
certificate and there is no information about the site of the first recurrence. This
large group of 235 unrecorded recurrences amounting to 37 per cent of the total
recurrence is a serious handicap in the present enquiry. In the face of such a
large group of unknown factors it is difficult to reach definite conclusions. What
can be done is to pick out those points which appear to be of special interest and
to study these more fully in a further investigation, when all the facts are known
about a larger proportion of the patients and when the difficulties inherent in all
follow-up studies carried out in war-time do not apply.
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The major sites of first recurrences (Table II) were found to be the bones and
the skin, with very little difference in incidence being recorded between the two
sites. Lung and pleura, regional lymph nodes, lymph nodes of the opposite side,
and liver were then found in that order of frequency. In the group of regional
lymph nodes were included the axillary, supraclavicular and parasternal nodes of
that side. There seemed to be surprisingly few cerebral and spinal cord meta-
stases-these were only 2-3 per cent of the total.
TABLE II.-Site ofFirst Detected Recurrences in 444
Patients with Cancer of the Breast.
2 recurrences were detected simultaneouisly in 76, 3 at once in 11,
4 in one and 5 in one other, making 105 more first detected recurrences
than patients.
Bones . . . . . . 134
Skin . . . . . . 127
Lung and pleura . . . . 86
Regional lymph nodes . . 70
Lymph nodes opposite side . . 50
Liver . . . . . . 37
Brain and spinal cord . . . 13
Mediastinal nodes . . . 7
Abdominal, other than liver . 6
Opposite breast . . . . 8
Original breast . . . . 5
Thyroid . . . . . 2
Other lymph nodes . . . 4
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The skin nodules were mainly to be found in the scar area following some form
of operative procedure, but some presented as a first recurrence in sites as widely
divergent as the scalp and groin.
The bone metastases were found predominantly in the vertebral column and
pelvis, with the remainder fairly equally divided between the ribs, skull, sternum,
and limb bones.
The remaining recurrences were few in number and scattered widely: in the
abdomen and mediastinum, other lymph nodes, the thyroid gland, and the origi-
nal and opposite breast. Recurrence in the original breast is claimed to have
occurred when a tumour has disappeared completely clinically following irradiation
and then re-appeared as a definite lump. Cases in which the tumour has never
quite regressed clinically are not included in the recurrence group but appear in
Table I inthegroup of348 casesinwhich the primary tumour was never controlled.
Cases with a metastasis in the opposite breast have been carefully studied to
eliminate the possibility that the tumour is a new primary. Ofthe cases in which
the tumour in the opposite breast has been assigned to the recurrence group,
6 have had other recurrences appearing sinmultaneously, and 2 further cases have
developed a mass in the opposite breast within a few months of treatment of the
original primary, and this has been quickly followed by the appearance offurther
widespread metastases.
Fig. 1 shows an analysis of these sites according to the year following first
treatment in which they occurred. This shows a high proportion of recurrences
ofallsites inthe first 3 years, falling alittle in the fourth and fifthyears, andbecom-
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ing relatively lower in the following years. Recurrence in one site does not seem to
predominate to any significant degree over any of the years studied. In this
figure the columns for each year show the sites of local recurrence (that is, the
scar and regional lymph nodes) grouped together at the base with the sites of
distant metastases above. There does not, however, seem to be any definite
relationship between the proportion oflocal to distant metastases in any particular
year.
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FiG. 1.-Analysis of first recurrences according to the sites of recurrence and the years in which
they occurred.
The duration of life following the first recurrence in those cases in which the
first-detected recurrence was confined to a single site is shown in Fig. 2. The
chief points of interest found here are the rapidity with which death follows first
recurrence in the liver, and to a slightly lesser degree recurrence in the lungs and
pleura. Skin manifestations as a first recurrence have a much more favourable
prognosis, Some patients are still living after the fifth year, and the majority
ofdeaths occur between 1 and 4 years after the recurrence appeared. Recurrence
in the vertebrae is also less rapidly fatal, the majority of deaths again occurring
between 1 and 4 years afterwards, with some patients surviving 5 years and in
one case as long as 8 years.
Fig. 3 shows a comparative analysis of first detected recurrences according to
the site oforigin ofthe original tumour in the breast. For this analysis 16 patients
with bilateral disease have had to be excluded.
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A small group of centrally situated tumours has been compared with those
diffusely infiltrating the breast. The remaining cases have been analysed in two
ways: firstly in the inner and outer halves of the breast, and then in the upper
and lower halves. A certain number of cases in which the site oforigin of the
tumour was not recorded have been excluded.
These findings suggest that there is little variation in the site of first-detected
recurrence with the position of the primary tumour in the breast. In fact the
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FIG. 2.-Distributions of durations from first recurrence to death or last follow-up, by site of
first recurrence (limited to recurrences confined to a single site).
* Died of cancer.
X Died of intercurrent disease.
O Alive.
only differences with any significance in this figure are the higher incidence of
first detected recurrence in lung and pleura from outer half breast tumours, and
in liver from upper half breast tumours-the opposite ofwhat would be expected.
These findings must be checked by further study, but if confirmed support the
conclusion drawn by us in a previous publication (Smithers et al., 1952) that
" the variation of prognosis with site of primary is due to less efficient treatment
for patients with inner-halftumours and the reason why this is shown particularly
in Stage I cases is that the proportion of inner-half tumours with lymph node
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involvement classified clinically as Stage I is probably higher than that for outer-
half tumours."
Fig. 4 shows a comparative analysis according to the stage of disease when the
patient was first seen. The two later stages, III and IV, have been combined
together for this investigation. Again, there is surprisingly little difference in
the site distribution of first-detected recurrence with stage of the disease at the
time ofthe first treatment. This adds furtherweight to the opinion that prognosis
chiefly determined by the nature of the tumour that the patient develops.
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FIG. 3.-A comparative analysis of first detected recurrences in carcinoma of the breast
according to the site oforigin ofthe original tumour. (Only recurrences up to 5 years used).
A group of patients with recurrence in the scar area following radical mastec-
tomy was taken and analysed according to whether they had received post-opera-
tive radiotherapy to the scar or not (Table III). The percentage offirst recurrence
in the first 5 years which involved the scar area is seen to be significantly higher
in the group not treated by radiotherapy, being 44 per cent as compared with
24 per cent in the other group.
A further group of patients was taken and studied in an effort to test the
effectiveness of parastemal irradiation. To this end the observed numbers of
first recurrences in the parasternal nodes occurring within the first 5 years in
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patients whose treatment had included parasternal irradiation, were compared
with the number of recurrences in the absence of parasternal irradiation. These
figures were compared for the various sites of the breast in which the primary
tumour had arisen and the results are shown in Table IV. This suggests that
parasternal irradiation is of value in preventing parasternal recurrence when the
tumour is in the inner half of the breast. However, when the primary tumour
arises in other sites, the recurrences of all types in the group which received
parasternal irradiation is too small to permit any definite conclusions.
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FIG. 4.-A comparative analysis offirst detected recurrences in carcinoma ofthe breast according
to the stage of the primary tumour. (Only recurrences up to 5 years used.)
CONCLUSION.
The findings recorded here need to be checked by analysing larger numbers
and using a more complete series. They suggest, however, that, judged by the
site of the first-detected recurrence, the pattern of dissemination does not depend
materially on the stage ofthe disease or the position ofthe primary tumour in the
breast. They support the opinion previously expressed that these things depend
more on the nature of the tumour than on any other factor.
This investigation is encouraging, however, in that it also suggests that within
the limits imposed on us by the character of the tumours which our patients
develop, much can be done to assist in controlling the spread. Irradiation reduces
the risks of recurrence in the skin and parasternal nodes, and may control the
spread seen when metastases have occurred-particularly in skin and in some
bones-sometimes for many years.
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TABLE Ill.-Recurrences in Scar Area.
A table to show the proportions of first recurrences which involved the
scar area for 2 groups of patients:
(a) Those who had post-operative H.V.T. to scar area.
(b) Those who had no post-operative H.V.T., or at least not to scar area.
(N.B.-Patients who had pre-operative H.V.T. are excluded.)
(a) H.V.T. to scar. (b) No H.V.T. to scar.
- ,
Year Scar Scar
of first area area
recur- recur- recur-
rence. rences. Others. Total. rences. Others. Total.
1 . 20 55 75 . 13 16 29
2 17 45 62 . 8 12 20
3 . 9 26 35 . 2 9 11
4 . 2 18 20 . 7 4 11
5 . 2 8 10 . 7 6 13
6 . 1 7 8 . 3 1 4
7 . 3 3 6 . 0 5 5
8 . 0 2 2 . 0 0 0
9 . 0 2 2 . 0 0 0
10 . 0 3 3 . 0 1 1
11 . 0 1 1 . 0 4 4
5 Year Total . 50 152 202 . 37 47 84
Percentage first recurrences in first 5 years which involved scar area: (a) 24 per
cent. (b) 44 per cent.
TABLE IV.-The Effectiveness ofParasternal Irradiation in
Preventing Early Parasternal Recurrence.
First treatment First treatment
including not including
parasternal irradiation. parasternal irradiation.
Site of r
primary Total first parasternal Total first parasternal
growth. recurrences. nodes. recurrences. nodes.
Inner half . 21 0 . 40 7
Outer half . 7 0 . 143 6
Central . . 3 0 . 30 0
Diffuse . . 1 0 . 35 0
Unspecified . 6 0 . 54 3
Total . 38 0 . 302 16
I would like to express my thanks to Professor D. W. Smithers for his helpful
advice in preparing this paper, and to Mir. P. M. Payne for his invaluable help in
the preparation ofthe tables and figures.
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